Transition from G2 to M phase of the cell cycle is controlled by:
**Core Concept**
The transition from the G2 phase to the M phase of the cell cycle is a critical checkpoint, ensuring that the cell is ready for mitosis. This transition is regulated by a complex interplay of cyclin-dependent kinases (CDKs) and their activating partners, the cyclins.
**Why the Correct Answer is Right**
Cyclin B, in particular, plays a key role in this transition. As the cell progresses from the G2 phase to the M phase, Cyclin B binds to and activates the CDK1 enzyme, also known as Cdc2. This Cyclin B-CDK1 complex drives the cell into mitosis by phosphorylating and inactivating proteins that prevent mitosis, such as Wee1 and Myt1. The Cyclin B-CDK1 complex also activates the anaphase-promoting complex (APC), which is responsible for the degradation of securin and cyclin A, allowing sister chromatids to separate.
**Why Each Wrong Option is Incorrect**
**Option A:** The retinoblastoma gene product (Rb) is a tumor suppressor protein that regulates the G1-S transition by binding to and inhibiting E2F transcription factors. While Rb is important for preventing uncontrolled cell growth, it is not directly involved in the G2-M transition.
**Option B:** p53 is a tumor suppressor protein that plays a crucial role in maintaining genomic stability by preventing cells with damaged DNA from entering the cell cycle. While p53 can induce cell cycle arrest or apoptosis in response to DNA damage, it is not directly involved in the G2-M transition.
**Option C:** Cyclin E is involved in the G1-S transition, where it binds to and activates CDK2, allowing the cell to progress from the G1 phase to the S phase. While Cyclin E is important for cell cycle progression, it is not directly involved in the G2-M transition.
**Clinical Pearl / High-Yield Fact**
The Cyclin B-CDK1 complex is a key regulator of the G2-M transition, and its dysregulation has been implicated in various cancers, including breast cancer and ovarian cancer. Abnormal expression of Cyclin B has been associated with poor prognosis and resistance to chemotherapy.
**✓ Correct Answer: D. Cyclin B. Cyclin B plays a crucial role in the transition from the G2 phase to the M phase of the cell cycle by binding to and activating the CDK1 enzyme.**